mounjaro tirzepatide news People Who Stopped Taking the Weight Loss Drug Regained Nearly Half the Weight They Lost What happens when you stop
Description
2022;34:10541063 e1057
They are not harmful for most people, but they should not be confused with the clinical effects of GLP-1 medications
Research published in kidney disease journals shows that GLP-1 receptor agonists do not cause acute kidney injury in patients with normal or mildly reduced kidney function
Is Wegovy the same as Mounjaro
Other Safety Considerations Several additional safety topics are relevant to the clinical use of orforglipron: Gallbladder events: GLP-1 receptor agonists have been associated with increased rates of cholelithiasis and cholecystitis, likely mediated by rapid weight loss altering bile composition and gallbladder motility
